Effectiveness of a Video-Based Lifestyle Education Program Compared to Usual Care in Improving HbA1c and Other Metabolic Parameters in Individuals with Type 2 Diabetes: An Open-Label Parallel Arm Randomized Control Trial (RCT)

被引:12
|
作者
Gupta, Uttio [1 ]
Gupta, Yashdeep [1 ]
Jose, Divya [2 ]
Mani, Kalaivani [3 ]
Jyotsna, Viveka P. [1 ]
Sharma, Gautam [2 ]
Tandon, Nikhil [1 ]
机构
[1] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi, India
[2] All India Inst Med Sci, Dept Cardiol, New Delhi, India
[3] All India Inst Med Sci, Dept Biostat, New Delhi, India
关键词
Asia; Behavioral; Diabetes; Education; India; Lifestyle;
D O I
10.1007/s13300-020-00769-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction This study was designed to investigate the effectiveness of a video-based lifestyle education program (VBLEP) in improving glycemic control in people with type 2 diabetes mellitus compared with usual care. Methods Patients on stable oral glucose-lowering agents for at least 3 months and HbA1c 7.5-10% were randomized in a 1:1 ratio. Primary outcome measure was the difference in change in mean HbA1c between groups. Results The participants (n = 81) had mean (+/- SD) age of 50.1 (+/- 9.4) years and HbA1c of 8.5 +/- 0.7% (68.87 +/- 7.56 mmol/mol). The follow-up data were available in 96% (78/81) of participants. Of 40 participants, 36 (90%) attended >= 75% (>= 3 out of 4) of the sessions in the VBLEP. In the intention-to-treat analysis, a significant reduction [0.6% 95% CI (0.1, 1.1), p = 0.013] in HbA1c was seen in the VBLEP group compared with usual care. A >= 1% reduction in HbA1c was observed in 39.5% of participants in the VBLEP compared with 15% in the usual care arm. However, a >= 0.5% reduction in HbA1c was observed in 65.8% of participants in the VBLEP compared with 37.5% in the usual care arm (p = 0.012). There was a significant change in weight and body mass index in the VBLEP group compared with usual care. The participants who were employed, had a family history of diabetes, had no diabetes-related complications, and were in the VBLEP group had higher odds of having a favorable HbA1c reduction (>= 0.5%, combined analysis both groups) from baseline. Conclusion The VBLEP demonstrated a significant and clinically relevant HbA1c reduction compared with usual care. A simple VBLEP, when delivered in an interactive manner, can aid in improving glycemic outcomes in the Indian population.
引用
收藏
页码:667 / 679
页数:13
相关论文
共 14 条
  • [1] Effectiveness of a Video-Based Lifestyle Education Program Compared to Usual Care in Improving HbA1c and Other Metabolic Parameters in Individuals with Type 2 Diabetes: An Open-Label Parallel Arm Randomized Control Trial (RCT)
    Uttio Gupta
    Yashdeep Gupta
    Divya Jose
    Kalaivani Mani
    Viveka P. Jyotsna
    Gautam Sharma
    Nikhil Tandon
    Diabetes Therapy, 2020, 11 : 667 - 679
  • [2] Effectiveness of yoga-based exercise program compared to usual care, in improving HbA1c in individuals with type 2 diabetes: A randomized control trial
    Gupta, Uttio
    Gupta, Yashdeep
    Jose, Divya
    Mani, Kalaivani
    Jyotsna, Viveka P.
    Sharma, Gautam
    Tandon, Nikhil
    INTERNATIONAL JOURNAL OF YOGA, 2020, 13 (03) : 233 - 238
  • [3] Effectiveness of a colour coded HbA1c graphical record in improving diabetes control in people with type 2 diabetes: A randomized control trial
    Wong, S. S. L.
    Ng, C. J.
    Liew, S. M.
    Hussein, N.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (02) : E41 - E44
  • [4] Effectiveness of the Telemedical Lifestyle Intervention Program TeLIPro for Improvement of HbA1c in Type 2 Diabetes: A Randomized-Controlled Trial in a Real-Life Setting
    Kempf, Kerstin
    Dubois, Clara
    Arnold, Matthias
    Amelung, Volker
    Leppert, Nora
    Altin, Sibel
    Vomhof, Markus
    Icks, Andrea
    Martin, Stephan
    NUTRIENTS, 2023, 15 (18)
  • [5] Improving type 2 diabetes detection among at-risk individuals - comparing the effectiveness of active opportunistic screening using spot capillary-HbA1c testing and venous HbA1c testing: a cluster randomized controlled trial
    Chan, Linda
    Yu, Esther Yee Tak
    Wan, Eric Yuk Fai
    Wong, Samuel Yeung Shan
    Chao, David Vai Kiong
    Ko, Welchie Wai Kit
    Chen, Catherine Xiao Rui
    Chan, Paul Po Ling
    Bilney, Emma Victoria Marianne
    Lee, Eng Sing
    Ng, Wei Leik
    Lam, Cindy Lo Kuen
    BMC MEDICINE, 2025, 23 (01):
  • [6] Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
    Matthias Blüher
    Julio Rosenstock
    Josef Hoefler
    Raymond Manuel
    Anita M. Hennige
    Diabetologia, 2024, 67 : 470 - 482
  • [7] Efficacy of lispro mix 25 BID versus glargine QD as starter insulin in patients with type 2 diabetes stratified by baseline HbA1c: subgroup analysis of a multi-national, randomized, open-label, parallel, controlled trial (DURABLE)
    Hou, Jianing
    Cao, Dachuang
    Qian, Lei
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 15 - 15
  • [8] Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
    Matthias Blüher
    Julio Rosenstock
    Josef Hoefler
    Raymond Manuel
    Anita M. Hennige
    Diabetologia, 2024, 67 : 758 - 758
  • [9] Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
    Blueher, Matthias
    Rosenstock, Julio
    Hoefler, Josef
    Manuel, Raymond
    Hennige, Anita M.
    DIABETOLOGIA, 2024, 67 (03) : 470 - 482
  • [10] Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): study protocol for a randomised, parallel open-label, intervention study focusing on HbA1c and glucose variability in patients with type 2 diabetes
    Ewers, Bettina
    Bruun, Jens Meldgaard
    Vilsboll, Tina
    BMJ OPEN, 2019, 9 (11):